YaoGeJu

Company directoryChina company filings

Fujian Haixi Pharmaceuticals Co., Ltd.

As of 20 November 2026, for the company name Fujian Haixi Pharmaceuticals Co., Ltd. as recorded, 11 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 34 records, across 27 drug names; since 23 August 2026, the records list Accepted: 5 applications, No longer listed under review: 2 applications (NMPA data as of 19 November 2026); the chemical-drug catalogue lists 10 active records with this name as holder.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

34 acceptance records as first applicant, grouped into 27 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

枸橼酸铋钾片 · No verified English name 1 records · Latest accepted 2026/10/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602640Generic2026/10/28Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Cinacalcet Hydrochloride Tablets 1 records · Latest accepted 2026/10/21

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2601925Supplement2026/10/21Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
布美他尼片 · No verified English name 1 records · Latest accepted 2026/10/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2602476Generic2026/10/10Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
HX9428片 · No verified English name 4 records · Latest accepted 2026/09/08

New drug · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2601091New drug2026/09/08Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
CXHL2601090New drug2026/09/08Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
CXHL2500117New drug2025/01/25Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
CXHL2500116New drug2025/01/25Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Teprenone Capsules 1 records · Latest accepted 2026/07/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601749Generic2026/07/21Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Tizanidine Hydrochloride Tablets 1 records · Latest accepted 2026/07/07

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601613Generic2026/07/07Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Doxycycline Hyclate Tablets 1 records · Latest accepted 2026/06/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601459Generic2026/06/22Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
HX1408片 · No verified English name 2 records · Latest accepted 2026/05/12

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2600556New drug2026/05/12Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
CXHL2600554New drug2026/05/12Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
腺苷钴胺胶囊 · No verified English name 2 records · Latest accepted 2026/04/09

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600702Supplement2026/04/09Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
CYHS2300876Generic2023/03/24Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Deferasirox Tablets 1 records · Latest accepted 2026/02/12

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600454Generic2026/02/12Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Lercanidipine Hydrochloride Tablets 1 records · Latest accepted 2026/01/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600050Generic2026/01/06Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Iguratimod Tablets 1 records · Latest accepted 2026/01/06

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2600049Generic2026/01/06Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Pinaverium Bromide Tablets 1 records · Latest accepted 2025/12/24

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504367Generic2025/12/24Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Polaprezinc Granules 1 records · Latest accepted 2025/08/04

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502808Generic2025/08/04Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Paracetamol and Ibuprofen Tablets 1 records · Latest accepted 2025/05/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501818Generic2025/05/20Fujian Haixi Pharmaceuticals Co., Ltd.; Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanizedCDE ↗
Pentoxifylline Modified Release Tablets 1 records · Latest accepted 2025/01/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500310Generic2025/01/15Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Benidipine Hydrochloride Tablets 1 records · Latest accepted 2024/05/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401585Generic2024/05/28Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Cetitizine Hydrochloride Oral Solution 1 records · Latest accepted 2023/12/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2303555Generic2023/12/21Fujian Haixi Pharmaceuticals Co., Ltd.; Hua Yi Tai Kang Pharma Co., Ltd. romanizedCDE ↗
Sodium Valproate Sustained-release Tablets(I) 1 records · Latest accepted 2023/09/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302527Generic2023/09/19Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.CDE ↗
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2023/08/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302208Generic2023/08/22Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Agomelatine Tablets 1 records · Latest accepted 2023/07/28

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302023Generic2023/07/28Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Amlodipine Besylate and Atorvastatin Calcium Tablets 2 records · Latest accepted 2023/06/03

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301279Supplement2023/06/03Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.CDE ↗
CYHB2301278Supplement2023/06/03Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.CDE ↗
C019199片 · No verified English name 2 records · Latest accepted 2023/02/11

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2300202New drug2023/02/11Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
CXHL2300201New drug2023/02/11Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Diclofenac Sodium Enteric-coated Tablets 1 records · Latest accepted 2023/01/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300232Generic2023/01/29Fujian Haixi Pharmaceuticals Co., Ltd.; Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.CDE ↗
瑞巴派特片 · No verified English name 1 records · Latest accepted 2022/12/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2202087Generic2022/12/21Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Hydroxychloroquine Sulfate Tablets 1 records · Latest accepted 2022/07/20

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201108Generic2022/07/20Fujian Haixi Pharmaceuticals Co., Ltd.; Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanizedCDE ↗
Nicergoline Tablets 1 records · Latest accepted 2022/06/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200980Generic2022/06/30Fujian Haixi Pharmaceuticals Co., Ltd.; ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD.CDE ↗

Changes in the last 90 days

7 events from 2026/08/23 to 2026/11/20. CDE data as of 2026/11/20; NMPA data as of 2026/11/19.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Accepted: 5 applicationsNo longer listed under review: 2 applications

  1. 2026/11/18No longer listed under review

    HX9428片 · No verified English name

    CXHL2601091

    Fact date: 2026/11/18 · Date added to this site: 2026/11/18

    Accepted: 2026/09/08

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  2. 2026/11/18No longer listed under review

    HX9428片 · No verified English name

    CXHL2601090

    Fact date: 2026/11/18 · Date added to this site: 2026/11/18

    Accepted: 2026/09/08

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  3. 2026/10/28Accepted

    枸橼酸铋钾片 · No verified English name

    CYHS2602640

    Fact date: 2026/10/28 · Date added to this site: 2026/10/29

    View source ↗
  4. 2026/10/21Accepted

    Cinacalcet Hydrochloride Tablets

    CYHB2601925

    Fact date: 2026/10/21 · Date added to this site: 2026/10/22

    View source ↗
  5. 2026/10/10Accepted

    布美他尼片 · No verified English name

    CYHS2602476

    Fact date: 2026/10/10 · Date added to this site: 2026/10/22

    View source ↗
  6. 2026/09/08Accepted

    HX9428片 · No verified English name

    CXHL2601091

    Fact date: 2026/09/08 · Date added to this site: 2026/10/22

    View source ↗
  7. 2026/09/08Accepted

    HX9428片 · No verified English name

    CXHL2601090

    Fact date: 2026/09/08 · Date added to this site: 2026/10/22

    View source ↗

Under review

11 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
枸橼酸铋钾片 · No verified English name CYHS2602640Generic2026/10/28Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Cinacalcet Hydrochloride Tablets CYHB2601925Supplement2026/10/21Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
布美他尼片 · No verified English name CYHS2602476Generic2026/10/10Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Teprenone Capsules CYHS2601749Generic2026/07/21Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Tizanidine Hydrochloride Tablets CYHS2601613Generic2026/07/07Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Doxycycline Hyclate Tablets CYHS2601459Generic2026/06/22Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Deferasirox Tablets CYHS2600454Generic2026/02/12Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Lercanidipine Hydrochloride Tablets CYHS2600050Generic2026/01/06Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Iguratimod Tablets CYHS2600049Generic2026/01/06Fujian Haixi Pharmaceuticals Co., Ltd.CDE ↗
Polaprezinc Granules CYHS2502808Generic2025/08/04Fujian Haixi Pharmaceuticals Co., Ltd.; Guangdong An Nuo Pharma Co., Ltd. romanizedCDE ↗
Paracetamol and Ibuprofen Tablets CYHS2501818Generic2025/05/20Fujian Haixi Pharmaceuticals Co., Ltd.; Zhejiang Hua Run San Jiu Zhong Yi Pharmaceutical Co., Ltd. romanizedCDE ↗

Catalogue holder records

10 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
Pentoxifylline Modified Release TabletsFujian Haixi Pharmaceuticals Co., Ltd.Guangdong An Nuo Pharma Co., Ltd. romanized国药准字H202648862026/06/17Generic approved under the new chemical-drug registration classificationCDE ↗
Benidipine Hydrochloride TabletsFujian Haixi Pharmaceuticals Co., Ltd.Guangdong An Nuo Pharma Co., Ltd. romanized国药准字H202550762025/07/30Generic approved under the new chemical-drug registration classificationCDE ↗
Bisoprolol Fumarate and Amlodipine Besylate TabletsFujian Haixi Pharmaceuticals Co., Ltd.Guangdong An Nuo Pharma Co., Ltd. romanized国药准字H202495422024/12/01Generic approved under the new chemical-drug registration classificationCDE ↗
Agomelatine TabletsFujian Haixi Pharmaceuticals Co., Ltd.Guangdong An Nuo Pharma Co., Ltd. romanized国药准字H202490112024/09/26Generic approved under the new chemical-drug registration classificationCDE ↗
腺苷钴胺胶囊 · No verified English nameFujian Haixi Pharmaceuticals Co., Ltd.Guangdong An Nuo Pharma Co., Ltd. romanized国药准字H202446392024/08/05Generic approved under the new chemical-drug registration classificationCDE ↗
Diclofenac Sodium Enteric-coated TabletsFujian Haixi Pharmaceuticals Co., Ltd.Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.国药准字H202442252024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
瑞巴派特片 · No verified English nameFujian Haixi Pharmaceuticals Co., Ltd.Guangdong An Nuo Pharma Co., Ltd. romanized国药准字H202436042024/04/24Generic approved under the new chemical-drug registration classificationCDE ↗
Amlodipine Besylate and Atorvastatin Calcium TabletsFujian Haixi Pharmaceuticals Co., Ltd.Ningbo Menovo Tiankang Pharmaceutical Co., Ltd.国药准字H202470712024/04/18Generic approved under the new chemical-drug registration classificationCDE ↗
Hydroxychloroquine Sulfate TabletsFujian Haixi Pharmaceuticals Co., Ltd.Fu An Pharma Group Qing Yu Tang Pharmaceutical Co., Ltd. romanized国药准字H202344112023/10/27Generic approved under the new chemical-drug registration classificationCDE ↗
Nicergoline TabletsFujian Haixi Pharmaceuticals Co., Ltd.ZHEJIANG JINGXIN PHARMACEUTICAL CO.,LTD.国药准字H202345742023/11/28Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
No matching records were found in the currently loaded source data; coverage dates are listed below.

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.